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Amorphous Calcium Phosphate 
as Bioactive Filler in Polymeric 
Dental Composites
Diane R. Bienek, Anthony A. Giuseppetti and Drago Skrtic
Abstract
As biocompatible and osteo-inductive precursor to biological apatite forma-
tion, amorphous calcium phosphate (ACP) resorbs at the rate that closely coin-
cides with the rate of new bone formation and is more osteo-conductive than its 
crystalline counterpart. In addition, in the oral environment, ACP intrinsically 
provides a protracted supply of the remineralizing calcium and phosphate ions 
needed for regeneration of mineral lost to tooth decay. These features make ACP 
composites a strong remineralizing tool at the site of caries attack. Our group 
has been on the forefront of the research on bioactive, remineralizing, polymeric 
ACP-based dental materials for over two decades. This entry describes methods 
for filler, polymer, and composite fabrication and a battery of physicochemical 
and biological tests involved in evaluation of ACP-based restoratives. Also pre-
sented is our most recent design of ACP remineralizing composites with added 
antimicrobial capability that shows promise for extended dental and, potentially, 
wider biomedical applications.
Keywords: amorphous calcium phosphate, bioactivity, dental composite,  
dental resin, remineralization
1. Introduction
Due to their abundance in nature as phosphate minerals and their existence in 
living organisms, calcium phosphates (CaPs) are of special significance to humans. 
CaPs are involved in normal (bones, teeth, antlers) as well as pathological (calcifi-
cation/mineral deposition in soft tissues) mineralization. Both normal and patho-
logical calcifications represent in vivo crystallization. In contrast, dental caries and 
osteoporosis are manifestations of in vivo dissolution where less soluble CaPs are 
being replaced by the more soluble ones. The extensive overviews of the current 
knowledge on CaP structures, properties, and biomedical and dental importance 
are provided in Refs. [1-4].
Amorphous calcium phosphates (ACPs) are unique members of CaP family with 
glass-like physical properties and variable chemistry [5]. Evidence of ACPs being 
an integral mineral component of bones and teeth is, however, ambiguous [6, 7]. 
Consequently, ACPs are considered the transient precursors in biomineralization 
[8–11] with the majority of information on their possible roles in biomineralization 
originating from the synthetic and/or in vitro studies [12].
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The use of CaPs in dentistry is roughly a century old with the first scientific 
article published in 1925 [3]. Majority of the literature on dental use of CaPs focuses 
on crystalline CaPs. Today, two ACP-based remineralization systems have been 
commercialized as a toothpaste: a casein phosphopeptide-stabilized ACP and an 
unstabilized ACP. Other ACP applications include various biocompatible formula-
tions where ACP acts as anticariogenic, remineralizing agent (polymeric compos-
ites, chewing gums, sugar confections, bleaching gels, and/or mouth rinses).
In this chapter, we present an overview of our group’s up-to-date work on ACP-
based dental composites with the emphasis on fabrication and characterization of 
ACP filler, fine-tuning of polymer phase, and physicochemical, mechanical, and 
biological evaluation of the ensuing polymeric ACP composites. Attention is also 
given to our most recent efforts to develop bioactive composites with both reminer-
alizing and antimicrobial (AM) capabilities.
2. ACP-based polymeric dental composites
The approaches to synthesize ACP include precipitation from supersaturated 
calcium and phosphate solutions (wet synthesis), spray drying of acidified aqueous 
solutions of soluble CaPs, precipitation from nonaqueous solutions and solvents 
(sol-gel technique), and dry chemical techniques (mechanochemical methods, 
high-energy processing at elevated temperatures). Morphology, chemical composi-
tion, atomic structure, thermal properties, mechanical properties, and kinetics 
of ACP’s transformation into crystalline CaPs depend on the preparation method 
[5]. ACPs fabricated by wet chemical method typically have a relatively constant 
chemical composition, suggesting the existence of well-defined structural units/
clusters [12, 13]. ACPs are thermodynamically unstable in solutions and convert 
spontaneously into crystalline CaPs, predominantly apatite. As result of ACP to 
apatite transformation, both crystallinity and Ca/P ratios of the solid increase with 
time. The release of remineralizing ions that accompany ACP’s transformation in 
solutions, coupled with their excellent biocompatibility and bioresorbability, makes 
ACP-based dental materials a powerful remineralizing tool. However, the unique 
benefit of ACP-based materials, i.e., their sustained remineralization capability, is 
compromised by the inherently low strength and toughness of ACP composites due 
to the uncontrolled agglomeration of ACP particles and enhanced water sorption 
(WS) on exposure to aqueous environment [14]. To overcome these deficiencies, 
we explored multiple approaches to reduce the heterogeneity of filler particle size 
distribution (PSD) and better control the stability of the ACP/resin interface. These 
attempts are described in Sections 2.1–2.3.
2.1 ACP filler: synthesis, characterization, and surface modification
ACPs utilized in our studies were synthesized according to the protocol 
originally proposed [15]. It was modified to include ab initio addition of cations 
or nonionic surfactants to Ca reactant and anionic surfactant or polymer to PO4 
reactant. In brief, ACP precipitated instantly upon mixing equal volumes of the 
reactant solutions {Ca reactant, 80 mmol/L Ca(NO3)2; PO4 reactant, 54 mmol/L 
Na2HPO4 + 2 mol% Na4P2O7 (to inhibit the precipitation of apatite simultaneously 
with ACP)} at 23°C and pH ≥ 8.5. After filtering, solid was subsequently washed 
with ice-cold ammoniated water, then with acetone, freeze-dried, and lyophilized. 
Dry, as-synthesized ACP (as-ACP) was kept in dessicator under vacuum before 
being subjected to additional treatments: silanization [16], grinding [17], or 
mechanical milling [14]. Before being utilized for composite fabrication, ACPs were 
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characterized (validated) by multiple screenings. The amorphousness of the solids 
was confirmed by X-ray diffraction (XRD) analysis and Fourier-transform infrared 
(FTIR) spectroscopy. PSD of ACP dispersed in isopropanol was determined by 
laser light scattering, and their morphology/topology of gold-sputtered specimens 
was assessed by scanning electron microscopy (SEM). ACP’s water content was 
measured by thermogravimetric analysis (TGA), and Ca/PO4 ratio was calculated 
from atomic emission spectroscopy data obtained upon dissolving ACP powder in 
HCl. Typical XRD pattern, FTIR spectrum, and SEM image of ACP are presented in 
Figure 1. More detailed description of ACP preparatory protocols and filler’s char-
acterization/validation is provided [18]. The same reference is also a good source of 
information on methods and techniques utilized in preparation and evaluation of 
copolymers and composites and their physicochemical, mechanical, and biological 
assessments discussed in Sections 2.2 and 2.3.
Introducing additives during ACP synthesis and/or applying secondary treat-
ments (Table 1) was expected to yield less clustered dry powders (more homo-
geneous and narrower PSD) and lead to better dispersion of ACP in the resin. 
Experimental details on surface modification protocols are provided in [16, 19]. 
More intimate ACP/resin contact is expected to enhance hydrolytic stability of 
ACP through lowering the WS, thus improving the mechanical performance of 
composites.
The coprecipitation of Ag and Fe phosphates and premature ACP to apa-
tite conversion in the presence of Fe2+ and Fe3+ disqualified these cations from 
further evaluation. Results of PSD analysis and TGA results obtained with 
surface-modified ACPs and strength testing of model 2,2-bis[p-(2′-hydroxy-3′-
methacryloxypropoxy) phenyl] propane (Bis-GMA)-based composites employing 
these fillers are summarized in Figure 2.
Regardless of the type of treatment, practically all ACPs preserved their hetero-
geneous PSDs. However, values of the median diameter (dm), i.e., the midpoint of 
the volume size distribution, of Zn-ACP and Al-ACP were significantly lower than 
the dms of all other ACPs subjected to surface modification and marginally lower 
than the dms of ground- (g-ACP) or milled- (m-ACP) solids. By comparing the PSD 
histograms and the corresponding SEM images (not shown here), it is concluded 
that the degree of particle agglomeration in Zn-ACP and Al-ACP has been modestly 
reduced—the quantification of the effect was not attempted. A similar conclusion 
was made after examining the PSDs and SEMs of g- and m-ACP vs. the control. The 
Figure 1. 
Representative XRD pattern (lower left corner) and FTIR spectrum (upper right corner) of ACP powder 
(center) with the corresponding SEM image (background).
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significant increase in dm of polymer-ACPs, on the other hand, could be attributed 
to the effect similar to “polymer bridging” seen in apatite/high-molecular-weight 
(Mw) polyacrylate system [18]. In theory, poly(ethylene oxide) (PEO)/ACP inter-
actions are controlled by the conformational changes in the adsorbed polymer, 
collision rate between the particles, and/or aggregate breakup due to fluid shear 
[20]. However, the exact controlling mechanism is yet to be determined.
The total content of surface-bound and/or structural water in all ACPs was 
unaffected by the treatment (on average (16.0 ± 1.2) mass%) and compared well 
with the control ((15.8 ± 3.9) mass%). Ideally, the lower intrinsic water content 
associated with less agglomerated ACP filler is desired to ensure favorable WS 
and ion release. WS of dental composites is generally controlled by structure/
composition of the resin matrix. In case of ACP composites, the hydrophilic filler 
increases the amount of water absorbed. In ACP/Bis-GMA composites [21], filler/
resin interface is inundated by the numerous voids that may enhance water dif-
fusion and hydration of the filler. These processes are better controlled in m-ACP 
composites [14].
A simple BFS [22] screening of Bis-GMA-based ACP composites (Figure 2) 
revealed the following order of mechanical stability upon extended (up to 
3 months) exposure to aqueous environment: (m-ACP ≥ g-ACP ≥ Zn-ACP = Z
r-ACP = silanized ACP) ≥ control (unmodified) ACP ≥ (Si-ACP ≥ surfactant-
ACPs) ≥ (Al-ACP = PEO-ACP). The observed decrease in BFS of ACP composites 
can, generally, be attributed to either reduction in ACP’s intactness caused by spa-
tial changes that occur in parallel to ion release, the internal ACP to apatite conver-
sion, or increased WS. The experimental finding that, after aqueous immersion, the 
BFS of Al-ACP and PEO-ACP composites deteriorated independently of their PSDs 
(dm of PEO-ACP was more than six times larger than that of Al-ACP, while their BFS 
was practically identical) suggests that fillers PSD has only a minor, if any, role in 
composite’s ability to resist plasticization/degradation upon water exposure. Our 
Additives Expected interactions/effect(s)
Cations
Ag+, Fe2+, Zn2+, Al3+, Fe3+, Si4+, 
Zr4+
ACP/cation interactions controlled by the cation’s ionic potential
Surfactants*
Anionic-Zonyl FSP As dispersants, surfactants prevent agglomeration of ACP particles 
and their coalescence with water
Nonionic-Triton100, Tween 80, 
Zonyl FSN
Polymer*
PEO (Mw 8 K, 100 K, 1000 K) Polymer stabilizes ACP particles via multiple chelation
Treatments
Silanization*
(APTMS, MPTMS) Silane agents stimulate formation of durable bonds at ACP/resin 
interface
Grinding Particle size reduced by friction
Ball milling Particle size reduced and PSD homogenized via high-energy impact 
and collision
*Acronyms are defined in the appended list of abbreviations.
Table 1. 
Surface modification of ACP: ab initio additives and secondary treatments.
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findings contradict an earlier report [23] that PEO strengthened the interface with 
ACP interface. Better understanding of the observed behavior may require further 
in-depth mechanical testing and water sorption/desorption evaluations. It appears 
prudent to consider approaches apart from the undertaken filler treatments, such 
as choice of monomers utilized in resin formulations, to design composites with 
optimized performance.
2.2 Resin matrix: fine-tuning a means of improving copolymer properties
The experimental resins were formulated from the commercially available base, 
diluent, and adhesive monomers activated for light-, chemical-, and/or dual (light 
and chemical)-cure (LC, CC, and DC, respectively). Monomers utilized in resin 
formulations and the ranges of their concentrations are listed in Table 2 (indicated 
acronyms will be used throughout this chapter). All commercial monomers were 
utilized as received, without any additional purification.
In LC formulations, all components were blended together and stirred at room 
temperature until reaching a uniform consistency. In CC formulations, monomers 
were first combined, their mixture homogenized and then divided into two equal 
parts by mass. The components of the CC initiating system are added separately to 
each monomer mixture and stirred magnetically until blended fully. In DC systems, 
LC and CC step were combined. LC and DC preparations required the use of yellow 
light to prevent the premature photopolymerization.
Copolymer specimens were prepared by packing resins into Teflon molds, 
covering each side of the mold with Mylar film and a glass slide, clamping assembly 
together, and, for LC and DC specimens, curing each side of the assembly with vis-
ible light for 2 minutes. Physicochemical tests routinely performed with copolymers 
involved assessment of degree of vinyl conversion (DVC; near-IR spectroscopy), 
WS (gravimetric measurements), and BFS.
Methacrylate-based dental resins typically entail high-viscosity base monomer 
(due to its larger molecular volume decreases polymerization shrinkage (PS) 
and enhances modulus of cured copolymer) and low-viscosity diluent monomer 
(due to its smaller molecular volume and greater flexibility enhances DVC and 
handling properties). Majority of contemporary dental resins is Bis-GMA-/
TEGDMA-based. Known drawbacks of Bis-GMA-based systems are relatively low 
DVCs, high PS, and susceptibility to hydrolytic and enzymatic degradation upon 
Figure 2. 
Effect of additives/treatments on PSD and water content of ACP solids and the biaxial flexure strength (BFS) 
following the aqueous immersion of composite specimens formulated with these fillers and bis-GMA resin. 
Indicated are mean values of minimum three independent runs and standard deviations (SD, represented by 
bars). Control ACP: as-ACP made without additives or a secondary treatment.
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exposure to oral fluids. In our resin fine-tuning studies, we have been explor-
ing the utility of EBPADMA and UDMA as the alternative base monomers and 
EHMA, HEMA, and PEG-U as the alternative diluent monomers. These studies 
are expected to yield valuable information on the interplay between the resin’s 
hydrophilicity/hydrophobicity, DVC, and mechanical stability and their effects 
on thermodynamic stability and mechanical performance of ACP composites 
fabricated with these resins.
Results of DVC and BFS screenings of Bis-GMA-, EBPADMA-, and UDMA-
based resins are compiled in Figure 3. The DVC values attained in our experimental 
formulations (ranging from 81.4 to 88.2%) with varying diluent and/or adhesive 
monomers (Table 2) significantly exceeded the typical DVC values reported for 
Bis-GMA/TEGDMA copolymers (60–70% [24]).
DVCs attained in Bis-GMA (81.4 ± 2.5%), EBPADMA (84.8 ± 5.5%), and 
UDMA (88.2 ± 2.2%) copolymers were significantly different (P < 0.05; Tukey 
post hoc test) only for UDMA vs. Bis-GMA systems. The BFS values, appar-
ently increasing in going from Bis-GMA to EBPADMA to UDMA copolymers 
(R2 = 0.9685), were significantly different (P < 0.05) only between UDMA and 
Bis-GMA copolymers. WS (data not shown) was not significantly affected by the 
resin’s compositional changes. In all three groups, maximum WS (values ranged 
from 2.3 to 3.0 mass%) was achieved within 2 weeks of aqueous immersion. Slight 
differences between the measured WS values could be related primarily to the 
inclusion of more hydrophilic (HEMA, TEGDMA) or less hydrophilic (EHMA, 
PEG-U) monomers in the resin matrix. It is, however, highly significant that all 
systems maintained the WS profiles that support a sustained ion release from the 
composites (see Section 2.3).
Component Chemical name Acronym Content 
(mass %)
Base monomers 2,2-Bis[p-(2′-hydroxy-3′-methacryloxypropoxy) 
phenyl] propane
Bis-GMA ≥68.4
Ethoxylated bisphenol A dimethacrylate EBPADMA ≤68.4
Urethane dimethacrylate UDMA ≤92.4
Diluent 
monomers
Ethyl-α-hydroxymethyl acrylate EHMA ≤29.2
2-hydroxyethyl methacrylate HEMA ≤30.4
Poly(ethylene glycol)-extended UDMA PEG-U ≤29.1
Triethylene glycol dimethacrylate TEGDMA ≤50.2
Adhesive 
monomers
Methacryloyloxyethyl phthalate MEP ≤5.0
Initiators Light cure
Camphorquinone CQ 0.2
Ethyl-4 N,N-dimethylamino benzoate 4EDMAB 0.8
Chemical cure
Benzoyl peroxide BPO 2
2,2-Dihydroxyethyl-p-toluidine DHEPT 1
Table 2. 
Methacrylate monomers and the components of polymerization-initiating systems utilized to fabricate the 
experimental resins.
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2.3 ACP composites: fabrication, physicochemical, mechanical, and biological 
assessments
To fabricate composites, resin (60 mass%) and ACP filler (40 mass%) were 
combined by hand spatulation. The homogenized paste was kept overnight under 
vacuum to eliminate the entrapped air before being utilized for preparation of test-
ing specimens by employing the procedures identical to those for the preparation of 
copolymer specimens. Besides DVC, BFS, WS, and PS testing, physicochemical and 
biological evaluation of composites also entailed polymerization shrinkage stress 
(PSS), shear bond strength (SBS) to dentin, ion release kinetics, leachability of 
unreacted species, remineralization efficacy, and in vitro cytotoxicity tests.
DVCs (Figure 4) of Zr-ACP composites formulated with various resins sig-
nificantly (ANOVA, Tukey test; P < 0.05) increased in going from Bis-GMA to 
EBPADMA to UDMA matrix. Higher DVC in UDMA systems could possibly be 
explained by the higher reactivity of UDMA than Bis-GMA and/or EBPADMA [25]. 
Resin composition, however, had no effect on the BFS of composites being ~50% 
lower than the BFS of their copolymer counterparts (compare BFS data in Figure 4 
vs. Figure 3). The reduction in BFS in UDMA-based composites (1.7%) was sig-
nificantly lower (P < 0.05) than reduction in BFS in Bis-GMA- to EBPADMA-based 
composites (10.0 and 4.4%, respectively). This finding suggests that random 
Figure 3. 
DVC and BFS of LC binary, ternary, and quaternary bis-GMA-, EBPADMA-, and UDMA-based 
copolymers. Indicated are mean values + SD (represented by bars) for n ≥ 24 (DVC) and n ≥ 12 (BFS).
Figure 4. 
DVC and BFS of LC Zr-ACP bis-GMA-, EBPADMA-, and UDMA-based composites. Indicated are mean 
values + SD (represented by bars) for n ≥ 24 (DVC) and n ≥ 12 (BFS).
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distribution of Zr-ACP agglomerates [21], rather than the resin matrix composition, 
controls the mechanical performance of composites.
Generally, WS {(3.3–3.8) mass%}, SBS {(15.3–17.5) MPa}, and PS {(6.5–
7.0) vol%)} results revealed no distinguishable differences between the Bis-GMA-, 
EBPADMA-, and UDMA-based composites. The observed increase in WS of 
composites vs. their copolymer counterparts (27–43%) was due to ACP’s affinity 
to the environmental water. It is significant that, in terms of SBS, ACP composites 
performed as well as Sr-glass filled composites [17], thus providing the remineral-
izing component to the primary restorative function without impediment of short- 
and midterm dentin bonding. High PS (undesirable) seen in all three experimental 
groups go hand in hand with the high DVCs (desirable) attained in these systems. 
These high PS values are likely due to the increased hydrogen bonding occurring 
in all experimental matrices leading to the densification of polymerization [26]. It 
is particularly important that, in UDMA-based composites, high PS can be offset 
by a significant hygroscopic expansion (HE; up to 13.6 vol%; data not shown). 
The compensating effect of HE on PS has been demonstrated in [27–29]. We were 
unable to establish any correlation between the PS and PSS in our experimental 
systems. Although contributions on this subject in dental literature are considerable 
[30–33], there is a question whether processing factors such as configuration factor 
(C-factor) besides the filler type and its load level, resin composition, and polymer-
ization mode control the composite performance [34].
Comparative kinetic study of ion release from Bis-GMA- and EBPADMA-
based composites showed a systematic increase in solution Ca and PO4 concen-
trations with the increased filler level in the composite and with time of aqueous 
immersion. Values of the ion activity product (IAP) used to calculate the relative 
supersaturation of the solutions with respect to the stoichiometric hydroxyapa-
tite (details on these calculations are provided in [35]) are presented in Figure 5. 
The ion release kinetics was practically identical in both types of composites. It 
was shown that a minimum of 35 mass% of ACP filler in composite is needed to 
create a sustained solution supersaturation inducive to apatite formation. The 
overall ion release kinetics in these systems was most likely controlled by the 
level of hydrophilic HEMA monomer in the resin phase. By more easily absorb-
ing the water needed for ion diffusion, HEMA regulated the internal mineral 
saturation levels.
Figure 5. 
Mean value + SD (indicated by bars) of the ion activity product (IAP) of the solutions containing Ca and PO4 
ions released from bis-GMA- and EBPADMA-based composites with various ACP levels (30, 35, or 40 mass%) 
at different times of immersion (1, 3, or 6 months) in saline solutions (23°C; continuous magnetic stirring). 
Number of repetitive experiments n = 3/group.
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In our studies, we conveniently use the DVC as a predictor of leachability (the 
higher the DVC, the lower the likelihood of unreacted monomers to leach) from the 
restorations. To quantify leaching from the UDMA/PEG-U/HEMA/MEP (UPHM) 
copolymers and their ACP composites, we have employed 1H-NMR spectroscopy. 
The accelerated leaching was mimicked by using acetone as extraction medium. 
Results are presented in Figure 6. Leaching (expressed as a mass fraction of the 
initial amount incorporated in the resin and normalized to the equivalent amount 
of the resin for composite specimens) decreased in the following order: 4EDMA
B > > MEP > UDMA > PEG-U > HEMA > CQ (undetectable). Introducing ACP 
filler into UPHM matrix did not have an impact on the leachability profile. In 
highly cross-linked UPHM matrix, polymer chain mobility remained small in both 
copolymers and composites, thus limiting the pathways for unreacted monomers 
to leach out from the specimens. The disproportionate leachability of 4EDMAB, a 
component of the LC initiator system, is most likely due to its excess relative to CQ 
(CQ:4EDMAB mass ratio 1:4), which appears to be fully consumed during polym-
erization and is undetectable in the extracts. Since HEMA is known for its increased 
toxicity and adverse side effects due to metabolizing to methacrylic acid [36], it 
is of high significance that the level of leachable HEMA from UPHM copolymers 
and composites is drastically (several orders of magnitude) lower than typically 
seen in HEMA-containing resins and composites. In addition, levels of leachable 
UDMA from UPHM matrices are more than twice lower than the amounts of 
leached UDMA from the experimental UDMA/TEGDMA formulations [37]. In the 
complex, high-DVC UPHM network, the mobility of the unreacted low-molecular-
weight HEMA is limited or reduced, and its elution to the environment is prevented.
In vitro cytotoxicity screening should be performed in conjunction with the 
leachability tests to better predict the material’s impact at cellular level. To mimic 
early ACP composite/cell interactions, we have performed the extraction experi-
ments and assessed cell morphology and cell viability according to the recom-
mended standards [38–40]. The osteoblast-like MC3T3-E1cells were seeded on 
ethanol-sterilized material disks, incubated in the extracts for 24 h, then evaluated 
in situ by optical microscopy, and assessed for cytotoxicity by tetrazolium-based 
{3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; MTT) assay. 
Detailed protocols are described in [41]. The results of the cytotoxicity evaluation 
of UPHM composites are presented in Figure 7. Cell morphology (Figure 7, inlets) 
changed from polygonal, spread (cells exposed to pure medium and extracts from 
UPHM copolymer and compressed ACP filler) to spherical (cells incubated in 
Figure 6. 
Leachables (mean value + SD (represented by bars); n = 3/group) detected by 1H-NMR spectroscopic method 
in acetone extracts from LC UPHM copolymers and their ACP composites (in composite series; values are 
normalized with respect to the initial resin amount).
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extracts from the experimental ACP UPHM composite and commercial control). 
Viability of contracted cells (i.e., those exposed to extracts from both composites) 
was reduced approximately twofold compared to the polygonal cell incubated in 
medium only. Similar morphological changes and slow cell proliferation observed 
in bone-regenerating hydrogels [42] are reportedly linked to the alterations in cell 
nucleus and mineralization of osteoprogenitors [43]. While fuller understanding 
of the cellular effects is certainly needed, it is encouraging that reduction in cell 
viability seen with our experimental composites was comparable with the commer-
cial control.
Remineralization efficacy studies were undertaken to demonstrate the abil-
ity of ACP composites to regenerate demineralized tooth structures. Details on 
the microradiographic in vitro evaluations of the changes in mineral content of 
the demineralized bovine and/or human enamel subjected to aggressive acid 
attacks, representative prolonged exposure in oral milieu, are provided in [44, 
45], respectively. These studies indicate that lost tooth mineral is indeed regener-
ated upon application of ACP composites (Figure 8). Mineral recovery with ACP 
Bis-GMA-based composites significantly exceeded the remineralization effect of 
Figure 8. 
Mineral recovery (or loss) following the pH regimens representing pH cycling in oral environment. Shown are 
mean values ± SD (indicated by bars) obtained from a minimum of eight micrographic images/experimental 
group.
Figure 7. 
Viability of osteoblast-like cells upon exposure to the extracts from ACP UPHM composite, commercial 
composite, medium + surfactant, and medium only. Shown are mean values = SD (indicated by bars) for three 
repetitive runs in each group. Optical micrographs indicating typical changes in cell morphology upon exposure 
to the extracts from composites (left side) and pure medium (right side).
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the glass-filled control. On average, more than threefold increase of mineral content 
attained with ACP EBPADMA-based composites compared to F-releasing control 
was, however, statistically insignificant due to a large data scattering. It is particu-
larly important that the regenerative action took place throughout the lesions in 
contrast to F-supported repair which is typically limited to a subsurface region.
2.4 Adding antimicrobial functionality to dental restoratives
To prolong service life, the next generation of polymeric dental restoratives 
is envisioned to possess bioactive properties. Today, developments of dental 
materials with embedded AM properties are relatively frequently reported. 
One of the first quaternary ammonium (QA) methacrylates integrated into 
Bis-GMA/TEGDMA matrix has been reported 20 years ago [46]. More 
recently, two polymerizable ionic dimethacrylates (2-(methacryloyloxy)-N-(2-
(methacryloyloxy)ethyl)-N,N-dimethylethan-1-aminium bromide (IDMA1) and 
N,N′-([1,1′-biphenyl]-2,2′-diylbis(methylene))bis(2-(methacryloyloxy)-N,N-
dimethylethan-1-aminium) bromide (IDMA2)) were proposed for use in dental 
applications [47, 48]. Purity of the synthesized materials was not reported, and 
the structural characterizations appeared incomplete. The IDMAs have been 
validated by nuclear magnetic resonance, mass spectroscopy, and FTIR spectros-
copies [49, 50]. These studies also included direct contact cytotoxicity testing at 
biologically relevant concentrations. To date, AM assessments of the fully charac-
terized IDMAs are remaining.
For the advancement of Class V restoratives, our goal was to evaluate the AM 
properties of purified/validated IDMA1 and IDMA2 integrated in dental copoly-
mers, using Streptococcus mutans (planktonic and biofilm).
IDMA copolymer disks (6 mm diameter) were fabricated by adding IDMA1 or 
IDMA2 (10 wt %) to light-activated UDMA/PEG-U/EHMA (hereafter UPE) resin. 
For both planktonic and biofilm testing, UPE disks were used as a negative control 
group. After fabrication, all copolymer disks were subjected to aqueous extrac-
tion (72 h, 37°C). After drying, specimens were sterilized using an Anprolene gas 
sterilization chamber (Andersen Products, Inc., Haw River, NC). Prior to bacterial 
testing, specimens were degassed for ≥5 days.
A bioluminescent S. mutans strain JM10 [51] (derivative of wild-type UA159) was 
used to assess the antibacterial properties, the IDMAs, employing a real-time bio-
luminescent assay developed by Florez et al. [52]. In UPE resin matrix, 10% IDMA1 
reduced (P ≤ 0.005) the colonization of S. mutans biofilms threefold (Figure 9). The 
initial report describing the synthesis of IDMA1 and incorporation into Bis-GMA-
TEGDMA resin conducted S. mutans testing with phosphate-buffered saline (i.e., 
no extrinsic proteins) [48]. Therein, they report reduced bacterial colonization for 
IDMA1 concentrations of 10, 20, or 30%. In the presence [53, 54] or absence [55] of 
ACP, others have demonstrated that IDMA1 fabricated with Bis-GMA/TEGDMA 
results in a modest (1.4–1.7-fold decrease in metabolic activity of biofilm) AM 
function in a protein-rich environment. To enhance AM activity, IDMA1 in combina-
tion with silver nanoparticles and/or nano-ACP was integrated into dental materials 
[53–56].
AM activity of IDMA2 has not been previously reported. Compared to the UPE 
control resin, our experiments demonstrated that IDMA2-UPE copolymer reduced 
(P ≤ 0.005) the colonization of S. mutans biofilms 1.6-fold (Figure 9). However, 
the AM activity of IDMA2 was less (P ≤ 0.05) than that observed with IDMA1. This 
difference may be due to steric hindrance resulting from the presence of aromatic 
rings in IDMA2. Further, it is noteworthy that IDMA2 can exist as a mixture of 
conformers. Thus, it is conceivable that the conformer (with decreased steric 
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hindrance) could exhibit greater AM activity. Future research that enables prepara-
tions, enriched for each conformer, is warranted to determine whether AM activity 
of IDMA2 can be enhanced.
For planktonic bacterial testing, S. mutans UA-159 (ATCC® 700610) cultures 
were established in Todd Hewitt broth (THB). Copolymer disks were seeded with  
S. mutans suspension (~3 × 107 colony-forming units/disk). To maximize the 
contact between the copolymer and bacteria, a second disk was placed atop. This 
assembly was incubated 2 h at 37°C in a 5% CO2 environment. The samples were 
then placed in 1 ml of THB and utilized to prepare 10-fold serial dilutions. Of the 
resulting suspensions, 100 μl were distributed onto the surface of THB agar plates. 
Colony-forming units were the unit of measure used to approximate the number 
of viable S. mutans cells after exposure to the IDMAs-UPE copolymers. Among the 
IDMA groups, the number of colony-forming units observed was not statistically 
different from one another or the UPE control resin (data not shown).
Altogether, the full AM potential of the IDMAs has not yet been realized. For 
example, the current IDMA restorative material formulations are likely to have 
charges randomly distributed throughout the material. It is conceivable that chemical 
engineering advances (i.e., material gradient or layers) could favor the orientation of 
the N+ charges while maintaining the material mechanical properties. Secondly, pre-
vious reports demonstrated that the presence of proteins dampens the AM capability 
of QA methacrylates (reviewed by [57]). To overcome this problem, a commercially 
available protein repellent, 2-methacryloyloxyethyl phosphorylcholine (MEPC), has 
been integrated into AM dental material [58]. However, because of possible binding 
of the remineralizing calcium ions by MEPC [59], MEPC may have a deleterious effect 
on the remineralization capacity of the restorative material. Generally, to date, there is 
a paucity of information regarding the nature of proteins binding to the surface of QA 
methacrylates. Elucidation of the protein-material interactions would yield valuable 
information to develop a strategy to maximize AM efficacy of materials with a charge-
based AM mechanism of action. Further, these data could facilitate the advancement 
of materials, modified to target specific proteins (i.e., via molecular imprinting).
Figure 9. 
Streptococcus mutans biofilm growth by the experimental IDMAs-UPE (10 wt %) copolymers compared to 
UPE resin. Presented are mean values ± SD (indicated by bars) of 5 specimens/experimental group. aP ≤ 0.05 
compared to IDMA2; bP ≤ 0.005 compared to UPE resin.
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3. Conclusions
Bioactive, ACP-based polymeric dental composites ACP have tremendous appeal 
due to their intrinsic ability to regenerate lost tooth mineral. ACP composites release 
remineralizing Ca and PO4 ions in a sustained fashion, thus providing a long-term 
protection against acid challenges in the oral environment. However, with respect 
to the mechanical strength and toughness, ACP-based composites are inferior to 
silanized glass-filled counterparts and can only be used in nonstress-bearing appli-
cations. The uncontrolled ACP particle agglomeration typically leads to the poor 
ACP filler/resin interactions that destabilize filler/polymer interface. A desired, 
more homogeneous PSD of ACP filler is achievable via mechanical treatments, pref-
erably high-energy milling. Surface modifications of ACP were proven less effective 
in that respect. With HEMA as diluent monomer, LC Bis-GMA-, EBPADMA-, and 
UDMA-based copolymers and their ACP composites typically attain high-DVC 
values that would suggest a minimal leaching of unreacted monomeric species from 
these materials. Expectedly, these high DVCs are accompanied with high PS. In 
UDMA-based systems, high PS is likely to be offset by a significant HE. High rem-
ineralization capabilities are achieved with EBPADMA or UDMA as base monomers 
and HEMA or EHMA plus PEG-U as diluent monomers. The most recent efforts in 
our group focus on design of bifunctional, remineralizing, and AM ACP composites 
that may find utility as new Class V restoratives. These materials are currently being 
assessed for their in vitro cytotoxicity and AM properties. The evaluations coupled 
with the leachability studies need to be completed before embarking on animal 
testing and/or human clinical trials involving AM ACP dental composites.
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A.Appendix: list of abbreviations
ACP amorphous calcium phosphate
ADA American Dental Association
ADAF American Dental Association Foundation
Al-ACP aluminum-modified ACP
AM antimicrobial
APTMS 3-aminopropyltrimethoxysilane
as-ACP as synthesized ACP
BFS biaxial flexure strength
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Bis-GMA 2,2-bis[p-(2′-hydroxy-3′-methacryloxypropoxy) phenyl] propane
BPO benzoyl peroxide
CaP calcium phosphate
CC chemical-cure
CQ camphorquinone
DC dual-cure
DHEPT 2,2-dihydroxyethyl-p-toluidine
dm median diameter
DVC degree of vinyl conversion
EBPADMA ethoxylated bisphenol A dimethacrylate
4EDMAB ethyl-4 N,N-dimethylamino benzoate
EHMA ethyl-α-hydroxymethyl acrylate
FTIR Fourier-transform infrared
g-ACP ground ACP
HE hygroscopic expansion
HEMA 2-hydroxyethyl methacrylate
IAP ion activity product
IDMA ionic dimethacrylate
IDMA1 2-(methacryloyloxy)-N-(2-(methacryloyloxy)ethyl)-N,N-dimeth-
ylethan-1-aminium bromide
IDMA2 N,N′-([1,1′-biphenyl]-2,2′-diylbis(methylene))bis(2-
(methacryloyloxy)-N,N-dimethylethan-1-aminium) bromide
LC light-cure
m-ACP milled ACP
MEP methacryloyloxyethyl phthalate
MEPC 2-methacryloyloxyethyl phosphorylcholine
MPTMS methacryloxypropyltrimethoxy silane
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
assay
Mw molecular weight
n number of specimens/experimental runs
PEG poly(ethylene glycol)
PEG-U PEG-extended UDMA
PEO poly(ethylene oxide)
PS polymerization shrinkage
PSD particle size distribution
PSS polymerization shrinkage stress
QA quaternary ammonium
SBS shear bond strength
SEM scanning electron microscopy
SD standard deviation
Si-ACP silica-modified ACP
TEGDMA triethylene glycol dimethacrylate
TGA thermogravimetric analysis
THB Todd Hewitt broth
Triton 100 C14H22O(C2H4O)10H; nonionic surfactant
Tween 80 C24H43O6(C2H4O)20H; nonionic surfactant
UDMA urethane dimethacrylate
UPE UDMA/PEG-U/EHMA resin
UPHM UDMA/PEG-U/HEMA/MEP resin
XRD X-ray diffraction
WS water sorption
Zn-ACP zinc-modified ACP
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Zr-ACP zirconia-modified ACP
Zonyl FSN F(C2F4)x(C2H4O)1+yH; nonionic surfactant (x = 1–9; y = 0–25)
Zonyl FSP F(C2F4)x(C2H4O)yHP(O)(ONH4)z; anionic surfactant (x = 1–7; 
(y + z) = 3)
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